✦ LIBER ✦

Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization

✍ Scribed by Tyler J. Gluckman; Jodi B. Segal; Natalie L. Fredde; Kenneth E. Saland; Jayesh T. Jani; Jeanine M. Walenga; M. Margaret Prechel; Kathleen M. Citro; David A. Zidar; Emily Fox; Steven P. Schulman; Thomas S. Kickler; Jeffrey J. Rade

Book ID: 113441747
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 95
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.11.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors for the Development of Elevat

Predictors for the Development of Elevated Anti-Heparin/Platelet Factor 4 Antibody Titers in Patients Undergoing Cardiac Catheterization

✍ Robert W. Yeh; Brendan M. Everett; Shi-Yin Foo; David J. Dorer; Michael Laposata 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Differential effects of clivarin and hep

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

✍ Sarfraz Ahmad; Sylvia Haas; Debra A Hoppensteadt; Helen Lietz; Ulrike Reid; Norb 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Laboratory Monitoring of Heparin and the

Laboratory Monitoring of Heparin and the Combination of Heparin and the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3) in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA)

✍ Ralf Zahn; Hannelore Haubelt; Sabine Bechtloff; Steffen Schneider; Birgit Frilli 📂 Article 📅 2003 🏛 Urban and Vogel 🌐 German ⚖ 356 KB

Effect of Heparin on Blood Vascular Endo

Effect of Heparin on Blood Vascular Endothelial Growth Factor Levels in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

✍ Małgorzata Pyda; Katarzyna Korybalska; Krzysztof Ksia̧żek; Stefan Grajek; Magdal 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Frequency of heparin/platelet factor 4-d

Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity

✍ Gremmel, Thomas; Frühwirth, Karin; Kopp, Christoph W.; Kaider, Alexandra; Steine 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 246 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB